Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Audiovestibular adverse event reporting profiles of GLP-1 receptor agonists: A case-case pharmacovigilance study using FDA AEMS data
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026
Body Weight Changes and Exploratory Metabolic Outcomes During Semaglutide and Tirzepatide Treatment: A Real-World Longitudinal Cohort Study from Türkiye
Journal of clinical medicine, 2026;15(20)
From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease
Frontiers in pharmacology, 2026;17:1784959
Characterizing the Adverse Event Profile of Semaglutide: A Comprehensive U.S. Food and Drug Administration Adverse Event Reporting System-Based Pharmacovigilance Study
Clinical nutrition ESPEN, 2026;:105169
GLP-1RA based treatment in patients with a PCSK1 mutation has profound effects on body weight – two case reports
Obesity facts, 2026;:1
Weight Maintenance Following Discontinuation of Semaglutide in an Adolescent with Antipsychotic-Associated Weight Gain: A Case Report
Hormone research in paediatrics, 2026;:1
Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity: The Gap Between Discussion and Use
Cardiology, 2026;:1
Tirzepatide use in adolescents with metabolic dysfunction-associated steatotic liver disease (MASLD): A case series
JPGN reports, 2026
The pharmacotherapy for pediatric obesity: insights and challenges from adult weight-loss medications
Journal of diabetes and metabolic disorders, 2026;25(2):289
Long-term metabolic regulation in the era of GLP-1 receptor agonists: An integrative review of Ayurvedic and biomedical perspectives
Journal of Ayurveda and integrative medicine, 2026;17(5):101406
Energy-Based Devices for GLP-1 Receptor Agonist-Associated Facial Aging: A Tissue-Specific Safety Framework
Clinical, cosmetic and investigational dermatology, 2026;19:628537
Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis
Diabetes, metabolic syndrome and obesity : targets and therapy, 2026;19:614243
Semaglutide Use and Risk of Diabetic Retinopathy and Non-Arteritic Anterior Ischemic Optic Neuropathy in Type 2 Diabetes: A Single-Center Retrospective Cohort Study
Clinical ophthalmology (Auckland, N.Z.), 2026;20:629343
12-month weight-loss trajectories and predictors of response to tirzepatide under individualized dosing: A multicenter real-world study
Obesity pillars, 2026;20:100344
Knowledge, attitudes, and practices among users of GLP-1 receptor agonists in Saudi Arabia: a cross-sectional study
Frontiers in pharmacology, 2026;17:1912202
A retrospective real-world study on semaglutide effectiveness in patients with obesity: differences between patients with and without food craving
Frontiers in endocrinology, 2026;17:1927180
From Lifestyle Advice to GLP-1 Agonists: The Transformation of Pediatric Obesity Care
Turkish archives of pediatrics, 2026;61(11):966-973
The Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis-A Narrative Review with a Translational Focus
Obesity reviews : an official journal of the International Association for the Study of Obesity, 2026;:e70228
Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms
Journal of clinical medicine, 2026;15(20)
Preconception incretin therapy reduces pregnancy and cardiometabolic outcomes in polycystic ovary syndrome
The Journal of clinical endocrinology and metabolism, 2026